Banyan Capital Management Inc. Sells 24,712 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Banyan Capital Management Inc. lowered its holdings in shares of Henry Schein, Inc. (NASDAQ:HSICFree Report) by 19.4% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 102,722 shares of the company’s stock after selling 24,712 shares during the period. Henry Schein accounts for approximately 4.3% of Banyan Capital Management Inc.’s holdings, making the stock its 12th largest position. Banyan Capital Management Inc.’s holdings in Henry Schein were worth $7,108,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of the business. Sumitomo Mitsui DS Asset Management Company Ltd increased its holdings in shares of Henry Schein by 2.7% in the third quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 12,994 shares of the company’s stock valued at $947,000 after purchasing an additional 340 shares during the last quarter. Blue Trust Inc. boosted its holdings in shares of Henry Schein by 157.0% during the 3rd quarter. Blue Trust Inc. now owns 2,393 shares of the company’s stock worth $174,000 after buying an additional 1,462 shares during the period. Tempus Wealth Planning LLC grew its stake in Henry Schein by 16.1% in the 3rd quarter. Tempus Wealth Planning LLC now owns 5,348 shares of the company’s stock valued at $390,000 after buying an additional 741 shares during the last quarter. Assenagon Asset Management S.A. raised its holdings in Henry Schein by 772.1% in the 3rd quarter. Assenagon Asset Management S.A. now owns 254,580 shares of the company’s stock valued at $18,559,000 after acquiring an additional 225,388 shares during the period. Finally, Cromwell Holdings LLC lifted its position in Henry Schein by 93.4% during the third quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock worth $26,000 after acquiring an additional 170 shares during the last quarter. Institutional investors and hedge funds own 96.62% of the company’s stock.

Henry Schein Trading Up 0.3 %

Shares of HSIC stock opened at $77.83 on Thursday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. Henry Schein, Inc. has a fifty-two week low of $63.67 and a fifty-two week high of $82.63. The company has a market cap of $9.70 billion, a PE ratio of 32.03, a P/E/G ratio of 2.15 and a beta of 0.91. The stock’s fifty day moving average price is $74.11 and its two-hundred day moving average price is $72.11.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on HSIC. Bank of America raised Henry Schein from an “underperform” rating to a “buy” rating and upped their target price for the company from $69.00 to $84.00 in a research report on Monday, January 6th. Jefferies Financial Group increased their price objective on Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research report on Thursday, January 23rd. Wells Fargo & Company began coverage on Henry Schein in a report on Friday, February 14th. They set an “equal weight” rating and a $80.00 target price for the company. StockNews.com upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. Finally, Mizuho initiated coverage on shares of Henry Schein in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price objective for the company. Eight equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $80.09.

View Our Latest Analysis on HSIC

Henry Schein Company Profile

(Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Further Reading

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSICFree Report).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.